To locate grants on a particular subject or the grants of a particular researcher, use the "Find" command in your Web browser to do a word search of this page.
The listing includes all active grants handled through the USC Dept. of Contracts & Grants. This information is updated on a quarterly basis. This listing is not intended to be a definitive source for the amount of grant awards, which should be obtained directly from the Department of Contracts and Grants. Users of this data are reminded also that there is a significant amount of grant activity not handled through the Department of Contracts & Grants and that this data is absent from this listing.
|
BERINGER, PAUL |
Pharmacokinetics of rosiglitazone alone and in combination with trimethoprim-sulfamethoxazole in adolescents and adult
patients |
1/1/2007 |
12/31/2007 |
$38232.00 |
Children's |
|
BERINGER, PAUL; LOUIE, STAN
G.;MAK, MAY C |
Impact of Abnormal Body
Composition on Predictability of Glomerular
Filtration Rate in HIV |
11/27/2006 |
5/31/2008 |
$46345.95 |
GlaxoSmithKline |
|
BRINTON, ROBERTA E. |
Estrogen-Induced Neuroprotective Mitochondria Mechanism |
6/1/2003 |
4/30/2008 |
$1320431.00 |
National Institute of
Mental Health |
|
BRINTON, ROBERTA E.; WANG,
JUNMING |
Allopregnanolone as a Neurogenic Factor
for Recovery of Neurons in Alzheimer's Disease |
2/15/2005 |
6/1/2008 |
$95000.00 |
Institute for the Study of
Aging |
|
BRINTON, ROBERTA E.;MACK,
W.;NILSEN, J.; |
Progesterone in Brain Aging
and Alzheimer's Disease |
8/15/2006 |
5/31/2011 |
$3115260.00 |
National Institute on Aging |
|
BURCKART, GILBERT J. |
Optimizing Outcome After
Pediatric Heart Transplantation |
2/15/2004 |
1/31/2009 |
$201323.00 |
|
|
CADENAS, ENRIQUE |
Oxidative Stress,
Mitochondrial Dysfunction, and Aging |
4/1/1999 |
5/31/2010 |
$976428.00 |
National Institute on Aging |
|
CADENAS, ENRIQUE |
Oxygen Radicals in Biology
GRC 2008 |
7/1/2007 |
6/30/2008 |
$5000.00 |
UC Berkeley -
Tobacco-Related Disease Research Program |
|
DAVIES, DARYL L. |
Important Sites of Ethanol
Action in Purinergic (P2X) Receptors |
9/1/2007 |
8/31/2010 |
$40972.00 |
National |
|
DAVIES, DARYL L.; ALKANA,
RONALD L. |
Pressure-Based
Pharmacological Alcoholism Treatments |
5/1/2003 |
4/30/2008 |
$487500.00 |
National |
|
DOCTOR, JASON N. |
Detecting Errors in Blood
Labs Using Bayesian Networks |
6/1/2007 |
5/31/2009 |
$260656.00 |
National Library of
Medicine |
|
GOAD, JEFFERY A.; OHNSON,
KATHLEEN A. |
Partners in D - Medicare
Outreach Program (MedOP): Training Pharmacists as
Patient Advocates |
3/1/2007 |
3/31/2010 |
$13889.00 |
|
|
HAMM-ALVAREZ, SARAH |
Modulation of Tear Protein
Secretion in the Lacrimal Gland |
7/1/2007 |
12/1/2007 |
$2000.00 |
Sjogren's Syndrome Foundation |
|
HAMM-ALVAREZ, SARAH |
Analysis of drug action on
functional and organizational parameters of secretory
vesicle exocytosis in licarimal
gland acinar cells |
7/1/2007 |
6/30/2008 |
$76694.00 |
Alcon Research, Ltd. |
|
HAMM-ALVAREZ, SARAH |
Ad5 Fiber Entry and
Trafficking in Lacrimal Acini |
4/3/2006 |
3/31/2011 |
$783972.00 |
National Eye Institute |
|
HAMM-ALVAREZ, SARAH;
OKAMOTO, CURTIS |
Trafficking of PlgRin Lacrimal Gland |
8/1/2006 |
6/30/2011 |
$601796.00 |
National Eye Institute |
|
HAMM-ALVAREZ,S.;MIRCHEFF,A.;SCHECHTER,J.YANG,A.; |
Microtubule-Based Transport
in Lacrimal Gland Function |
7/1/1996 |
3/31/2009 |
$1424596.00 |
National Eye Institute |
|
HWANG, JULIANA Y. |
Effects of Progesterone and
Progestin on MMP: Implications for Plaque Rapture |
10/2/2006 |
10/1/2009 |
$20200.00 |
Columbia Labs, Inc. |
|
JOHNSON, KATHLEEN A. |
Implementation of
Pharmacist Clinical Services to Improve Health Outcomes of Asthmatic Children
in |
7/1/2004 |
4/1/2008 |
$452475.00 |
Unihealth Foundation |
|
JOHNSON, KATHLEEN A. |
HUGS Cost of Hemophilia
Study |
7/1/2004 |
6/30/2008 |
$605000.00 |
HUGS-V Various
Pharmaceutical Companies |
|
JOHNSON, KATHLEEN A. |
Expansion of Pharmacist
Services in QueensCare Community Clinics |
5/1/2006 |
4/30/2009 |
$737576.00 |
QueensCare Foundation |
|
JOHNSON, KATHLEEN A. |
Student Pharmacist
Volunteer Program in Clinics for Medically Underserved Patients (SHARE
Program) |
1/1/2004 |
12/31/2007 |
$29200.00 |
Merck Company Foundation |
|
LOUIE, STAN G. |
Prediction of patients with
increased risk of renal insufficiency using pharmacokinetics and pharmacogenomics analysis |
5/15/2007 |
4/30/2009 |
$76927.50 |
Glaxo, Inc. |
|
LOUIE, STAN G. |
CCTG 584: Viral Dynamics
and Pharmacokinetics of TDF and ABC Monotherapy
versus the combination therapy of TDF -ABC in HIV Infected Nave Patients |
11/15/2004 |
6/30/2008 |
$16531.20 |
|
|
LOUIE, STAN G.; AN, HAEJUNG |
Randomized, parallel-Group,
Placebo-Controlled Clinical Trial Evaluating the Safety and Tolerance of
NorLeu3-Angiotensin II (1-7)(USB001) Following Daily Applications to Intact
Skin Sites |
7/1/2007 |
9/1/2008 |
$20000.00 |
US BioTest |
|
MC COMBS, JEFFREY S. |
Impact of Atypical Antipsychotics on Patient Outcomes and Treatment Costs
for Patients with Schizophrenia and Bipolar Disorders |
12/6/2006 |
12/31/2007 |
$95000.00 |
Bristol-Myers Squibb
Company |
|
MC COMBS, JEFFREY S. |
Pharmacoeconomics Graduate Fellowship |
7/1/2004 |
8/1/2008 |
$218020.00 |
Eli Lilly & Company |
|
NEAMATI, N.; DUBEAU, L.;
CONTI, P. |
Preclinical Development of
SC144, the First Small-Molecule Inducer of IL24 |
9/1/2007 |
10/1/2010 |
$815000.00 |
|
|
NEAMATI, NOURI |
Preclinical Development of
SC14 in Metastatic |
7/1/2006 |
6/30/2008 |
$250000.00 |
American Association for
Cancer Research-Gertrude |
|
NEAMATI, NOURI |
Preclinical Development of
SC21 in Lung Cancer |
7/1/2006 |
6/30/2008 |
$100000.00 |
American Lung Association, |
|
NEAMATI, NOURI |
Design of Second Generation
HIV-1 Integrase Inhibitors |
7/1/2006 |
6/30/2008 |
$88000.00 |
|
|
NEAMATI, NOURI; DUBEAU,
LOUIS |
Integrin avb3 targeted drug design, delivery, and imaging |
9/30/2007 |
7/31/2012 |
$229798.00 |
National Cancer Institute |
|
NICHOL, MICHAEL B. |
Healthy Employee Adherence
Research Trial (Heart) |
1/10/2007 |
1/31/2008 |
$102482.00 |
Pfizer, Inc. |
|
NICHOL, MICHAEL B. |
VOM Project |
11/27/2006 |
11/30/2007 |
$33937.50 |
GlaxoSmithKline |
|
NICHOL, MICHAEL B. |
Evaluating Medication
Compliance in a CareMark Managed Care Population |
7/24/2006 |
12/31/2007 |
$71250.00 |
GlaxoSmithKline |
|
NICHOL, MICHAEL B. |
Evaluation of Pitney Bowes
Predictive Modeling Approach |
3/10/2006 |
2/1/2008 |
$85000.00 |
Pfizer, Inc. |
|
NICHOL, MICHAEL B. |
A Simulation Model for
Employer Health Benefit Decision Making: Funding Prospectus for Phase I |
6/1/2006 |
11/15/2007 |
$100000.00 |
Benefit Design Institute |
|
SHEN, WEI-CHIANG |
Membrane Transduction
Peptides for Drug Delivery |
9/1/2005 |
8/31/2009 |
$783523.00 |
National |
|
SHEN, WEI-CHIANG |
Recombinant Transferrin-Human Growth Hormone Fusion Protein for Oral
Drug Delivery |
11/14/2005 |
5/3/2008 |
$247463.00 |
Pfizer, Inc. |
|
SHEN, WEI-CHIANG; HAWORTH,
IAN S. |
Transferrin Conjugates for Oral Protein Drug Delivery |
4/1/2002 |
3/31/2011 |
$260800.00 |
National |
|
SHIH, JEAN C.; CHEN, KEVIN |
Two Types of Monoamine Oxidase |
9/1/1985 |
3/31/2008 |
$2467876.30 |
National Institute of
Mental Health |
|
SHIH,
JEAN C; CHEN, KEVIN. |
The Transcriptional
Regulation of Monoamine Oxidase A |
8/1/2004 |
6/30/2009 |
$1421159.00 |
National Institute of
Mental Health |
|
SOHAL, RAJINDAR |
Mechanisms of Cognitive
Decline During Aging - Project 1 |
9/30/2003 |
8/31/2008 |
$500147.00 |
|
|
SOHAL, RAJINDAR |
Glutathione, Oxidative
Stress, and Aging |
1/1/2001 |
3/31/2011 |
$322361.00 |
Southern |
|
SOHAL, RAJINDAR |
Dietary Modulation of
Cellular Oxidative Stress in Aging |
4/1/1996 |
7/31/2008 |
$2122754.57 |
National Institute on Aging |
|
SOHAL, RAJINDAR |
Cellular Aging and Oxygen
Free Radicals |
8/1/1988 |
3/31/2012 |
$338420.00 |
National Institute on Aging |
|
STILES, BANGYAN L |
The Role of Pten in B-CellRegeneration
through Epithelial-Mesenchymal Transition |
7/1/2007 |
6/30/2009 |
$163000.00 |
National Institute of
Diabetes & Digestive & Kidney Diseases |
|
VANDERVEEN, RANDALL L. |
Health Professions Student
Loan (HPSL) |
7/1/2007 |
6/30/2008 |
$23843.00 |
Bureau of Health
Professions |
|
VANDERVEEN, RANDALL L. |
Scholarships for
Disadvantaged Students (SDS) |
7/1/2005 |
6/30/2008 |
$650000.00 |
Health Resources &
Services Administration |
|
WANG, CLAY CHIA CHUN |
Biomechanism Based Drug Design in Escherichia Coli |
1/1/2006 |
12/31/2009 |
$720000.00 |
American Cancer Society,
Inc. |
|
WANG, CLAY CHIA CHUN |
Platforms for nonribosomal peptide manipulation |
9/23/2005 |
7/31/2008 |
$834266.00 |
National |
|
WOLF, WALTER |
Establishment and Operation
of the Multidisciplinary Advisory Council for Noninvasive Imaging Studies
(MACNIS) |
9/6/2007 |
9/5/2008 |
$10000.00 |
Food and Drug
Administration |
|
WOLF, WALTER |
Pharmacokinetic/Pharmacodynamic (PK/PD) Study of the Effect of Gleevec on Tumor Vascularity
and on Gemcitabbine Uptake Using Non-Invasic MRI/MRS |
1/1/2005 |
12/31/2010 |
$95839.20 |
Novartis Pharmaceuticals
Corporation |
|
WONG-BERINGER, ANNIE |
Impact of Fluoroquinolone Resistance on Pseudomonas Virulence and
Patient Outcome |
7/1/2006 |
12/30/2007 |
$30000.00 |
|
|
WONG-BERINGER, ANNIE |
Prevalence of Panton-Valentine Leukocidin-Producing
MRSA among Hospitalized Patients and Implications on Therapy |
3/14/2007 |
4/1/2009 |
$56250.00 |
Pfizer, Inc. |